The Week Ahead: Perform set to put on a good show


Perform Group's update today should come as a pleasing spectacle for shareholders – that is, if they're able to tear themselves away from vegging out in front of the US Open, WTA Tour, NBL Basketball, Russian 1st Division, South American league or one of the many other sports covered by their company. The digital rights business continues to build its portfolio, and analysts at Numis rate it a Buy with a share price target of 509p. Paul Richards said the group's "streaming, data, editorial and statistical products" make it one of his "key picks" this year.

Results/Updates: Rugby Estates, F&C Asset Management, Advent Capital, Lancashire Holdings, Lok'nStore, Tristel.


Fags aren't good for your health but shares in one of the makers of them could be good for your bank balance, according to scribes at Deutsche Bank. Jonathan Fell admits: "As revealed in the trading update, this will be one of Imperial's strongest-ever years of organic sales growth, and in the EU we expect it to have produced better growth than peers. It is our strong view that Imperial's business is very much more robust than the valuation gives it credit for." He rates the shares a Buy with a price target of 3,000p. Investors are expecting a final dividend, payable in mid-February of 72.9p.

Results/Updates: BP, Stagecoach Group Standard Chartered, Wolfson Microelectronics, Luminar, Endace, Schroders, BNS Telecom, Surfcontrol.


Whether or not you still hate bankers, Investec banking expert Ian Gordon says it is time to buy Barclays shares. Ahead of its update on Wednesday, Mr Gordon gives the shares a price target of 255p and says: "Barclays confirms that it will broadly meet (rather than beat) raised expectations". He points out Barclays trades at a discount to Lloyds, which he rates a Sell. The analyst consensus expects sales of £2.8bn for the third quarter. But Mr Gordon said he is more focused on its cost line. He said: "If Barclays can deliver here, and we increasingly believe that it can, a sustainable cost/net operating income ratio of 60-65 per cent may become a reality. For the survivors, the shareholder economics of investment banking are certainly looking up."

Results/Updates: First Quantum Minerals, Braemar Shipping Services, F&C Asset Management, GlaxoSmithKline, Lamprell, Mondi, Next, Phoenix Group, St James's Place, Standard Life, Kerry Group, Volex.


Is it time to dial up BT? Scribes at Liberum Capital recommend buying the shares of the telecoms group, and have given them a price target of 260p ahead of its results on Thursday. Liberum thinks it will give details of a "deteriorating revenue picture" but despite the bad news its analysts think that this is priced into the shares. They expect "the revenue trends to start to improve in the half year and that the improvement will be more visible into next". BT's good cost controls should also be evident in the results.

Results/Updates: Avocet Mining, BG Group, BSkyB, Croda, Glencore, Henderson, Legal & General, Lloyds Banking Group, Royal Dutch Shell, Smith & Nephew, Taylor Wimpey, Icon.


The defence and aerospace sector has been in focus recently, with BAE Systems' failed merger with EADS, vague speculation that Senior could be a takeover target and Carlyle's waning interest in Chemring. But on Friday it is Meggitt's turn to be in the spotlight. Analysts at Galvan Research regard the current lows of its shares as a "buy-the-dips opportunity" especially taking into account two summer contract wins and the reiteration of full-year guidance in August. They give the shares a target price of 402p.

Results/Updates: Admiral, Direct Line, Millennium & Copthorne Hotels, Wincanton, Royal Bank of Scotland, Biome Technologies.

Start your day with The Independent, sign up for daily news emails
ebooksA celebration of British elections
  • Get to the point
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Ashdown Group: Editor-in-chief - Financial Services - City, London

£60000 - £70000 per annum + benefits : Ashdown Group: A highly successful, glo...

Ashdown Group: Junior Application Support Analyst - Fluent German Speaker

£25000 - £30000 per annum + benefits: Ashdown Group: A global leader operating...

Guru Careers: Management Accountant

£27 - 35k + Bonus + Benefits: Guru Careers: A Management Accountant is needed ...

Guru Careers: Project Manager / Business Analyst

£40-50k + Benefits.: Guru Careers: A Project Manager / Business Analyst is nee...

Day In a Page

General Election 2015: ‘We will not sit down with Nicola Sturgeon’, says Ed Balls

'We will not sit down with Nicola Sturgeon'

In an exclusive interview, Ed Balls says he won't negotiate his first Budget with SNP MPs - even if Labour need their votes to secure its passage
VE Day 70th anniversary: How ordinary Britons celebrated the end of war in Europe

How ordinary Britons celebrated VE Day

Our perception of VE Day usually involves crowds of giddy Britons casting off the shackles of war with gay abandon. The truth was more nuanced
They came in with William Caxton's printing press, but typefaces still matter in the digital age

Typefaces still matter in the digital age

A new typeface once took years to create, now thousands are available at the click of a drop-down menu. So why do most of us still rely on the old classics, asks Meg Carter?
Discovery of 'missing link' between the two main life-forms on Earth could explain evolution of animals, say scientists

'Missing link' between Earth's two life-forms found

New microbial species tells us something about our dark past, say scientists
The Pan Am Experience is a 'flight' back to the 1970s that never takes off - at least, not literally

Pan Am Experience: A 'flight' back to the 70s

Tim Walker checks in and checks out a four-hour journey with a difference
Humans aren't alone in indulging in politics - it's everywhere in the animal world

Humans aren't alone in indulging in politics

Voting, mutual back-scratching, coups and charismatic leaders - it's everywhere in the animal world
Crisp sales are in decline - but this tasty trivia might tempt back the turncoats

Crisp sales are in decline

As a nation we're filling up on popcorn and pitta chips and forsaking their potato-based predecessors
Ronald McDonald the muse? Why Banksy, Ron English and Keith Coventry are lovin' Maccy D's

Ronald McDonald the muse

A new wave of artists is taking inspiration from the fast food chain
13 best picnic blankets

13 best picnic blankets

Dine al fresco without the grass stains and damp bottoms with something from our pick of picnic rugs
Barcelona 3 Bayern Munich 0 player ratings: Lionel Messi scores twice - but does he score highest in our ratings?

Barcelona vs Bayern Munich player ratings

Lionel Messi scores twice - but does he score highest in our ratings?
Martin Guptill: Explosive New Zealand batsman who sets the range for Kiwis' big guns

Explosive batsman who sets the range for Kiwis' big guns

Martin Guptill has smashed early runs for Derbyshire and tells Richard Edwards to expect more from the 'freakish' Brendon McCullum and his buoyant team during their tour of England
General Election 2015: Ed Miliband's unlikely journey from hapless geek to heart-throb

Miliband's unlikely journey from hapless geek to heart-throb

He was meant to be Labour's biggest handicap - but has become almost an asset
General Election 2015: A guide to the smaller parties, from the the National Health Action Party to the Church of the Militant Elvis Party

On the margins

From Militant Elvis to Women's Equality: a guide to the underdogs standing in the election
Amr Darrag: Ex-Muslim Brotherhood minister in exile still believes Egypt's military regime can be replaced with 'moderate' Islamic rule

'This is the battle of young Egypt for the future of our country'

Ex-Muslim Brotherhood minister Amr Darrag still believes the opposition can rid Egypt of its military regime and replace it with 'moderate' Islamic rule, he tells Robert Fisk
Why patients must rely less on doctors: Improving our own health is the 'blockbuster drug of the century'

Why patients must rely less on doctors

Improving our own health is the 'blockbuster drug of the century'